The SSM warns about the irregular sale of Combovir, an unregistered medicine that promises to cure COVID-19
Morelia, Michoacán.- The Ministry of Health of Michoacán (SSM)through the State Commission for the Protection against Health Risks (Coepris)alerts the population about the irregular sale of the medicine Combovir (nirmatrelvir 150 mg/ritonavir 100 mg), in tablet presentation, since it does not have a health registration for its sale in Mexico and that promises to treat COVID-19.
This product is manufactured by Bruck Pharma Private Limited and was detected being marketed on digital platforms, with a risk to health, by not guaranteeing its safety and effectiveness.
You may also be interested in: Get vaccinated against influenza at any of the 364 SSM centers
Therefore, the population is recommended not to purchase medications through social networks, sales platforms or other online sites, mainly those that are offered at low prices and that require prescription and medical supervision and only do so in pharmacies.
If you have information about its possible commercialization, citizens are urged to make the corresponding health complaint through email: denuncias.coepris@salud.michoacan.gob.mx.
The authorization of products for the treatment of COVID-19 is carried out in a controlled manner by the Federal Commission for the Protection against Sanitary Risks (Cofepris), and Combovir has not presented to the health authority evidence or guarantee of the characteristics of identity, purity, safety and effectiveness to obtain registration and be able to be sold and manufactured, which is why it represents a risk to the health of the population.
